Axillary Lymph Node Status and neoadjuvant Therapy in HER2-positive Breast Carcinoma

被引：0
|
作者：
Danzinger, S. [1 ]
Pfeifer, C. [2 ]
Wimmer, S. [1 ]
Tendl-Schulz, K. [3 ]
Singer, C. F. [1 ]
机构：
[1] Med Univ Wien, Univ Klin Frauenheilkunde, Vienna, Austria
[2] Univ Innsbruck, Inst Stat, Innsbruck, Austria
[3] Med Univ Wien, Klin Inst Pathol, Vienna, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 04期
关键词：
D O I：
10.1055/s-0043-1766396
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
005
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
    Guo, Xuhui
    Zhang, Jiao
    Gong, Xilong
    Wang, Jia
    Dai, Hao
    Jiao, Dechuang
    Ling, Rui
    Zhao, Yi
    Yang, Hongjian
    Liu, Yunjiang
    Liu, Ke
    Zhang, Jianguo
    Mao, Dahua
    He, Jianjun
    Yu, Zhigang
    Liu, Yinhua
    Fu, Peifen
    Wang, Jiandong
    Jiang, Hongchuan
    Zhao, Zuowei
    Tian, Xingsong
    Cao, Zhongwei
    Wu, Kejin
    Song, Ailin
    Jin, Feng
    Fan, Zhimin
    Liu, Zhenzhen
    BREAST, 2024, 73
  • [32] De-escalating axillary surgery according to neoadjuvant single or dual HER2 blockade in clinically node-positive, HER2-positive breast cancer
    Cha, C.
    Kim, D.
    Lee, J.
    Park, S.
    Bae, S. J.
    Kim, J. Y.
    Ahn, S. G.
    Park, H. S.
    Park, S.
    Kim, S. I.
    Cho, Y. U.
    Jeong, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation
    Hiroyuki Takei
    Takashi Yoshida
    Masafumi Kurosumi
    Kenichi Inoue
    Hiroshi Matsumoto
    Yuji Hayashi
    Toru Higuchi
    Sayaka Uchida
    Jun Ninomiya
    Kazuyuki Kubo
    Hanako Oba
    Shigenori Nagai
    Toshio Tabei
    International Journal of Clinical Oncology, 2013, 18 : 547 - 553
  • [34] Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation
    Takei, Hiroyuki
    Yoshida, Takashi
    Kurosumi, Masafumi
    Inoue, Kenichi
    Matsumoto, Hiroshi
    Hayashi, Yuji
    Higuchi, Toru
    Uchida, Sayaka
    Ninomiya, Jun
    Kubo, Kazuyuki
    Oba, Hanako
    Nagai, Shigenori
    Tabei, Toshio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 547 - 553
  • [35] Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?
    Harbeck, Nadia
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [36] ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy
    Li, Jian-wei
    Mo, Miao
    Yu, Ke-da
    Chen, Can-ming
    Hu, Zhen
    Hou, Yi-feng
    Di, Gen-hong
    Wu, Jiong
    Shen, Zhen-zhou
    Shao, Zhi-ming
    Liu, Guang-yu
    PLOS ONE, 2014, 9 (12):
  • [37] Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor Positive, HER2 Negative Breast Cancer Patients
    Friedman-Eldar, O.
    Ozmen, T.
    Reyes, F. Valle
    Goel, N.
    Tjendra, Y.
    Moller, M.
    Kesmodel, S. B.
    Franceschi, D.
    Avisar, E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S68 - S68
  • [38] HER 2 Neu Positive Status of the Primary Tumor Predicts Axillary Lymph Node Response in ER/PR plus , Node Positive Patients Receiving Neoadjuvant Chemotherapy
    Sparber, L.
    Murthy, V.
    Carey, E.
    Schaefer, S.
    Santoro, E. J.
    McDermott, J.
    Chamberlain, R. S.
    Blackwood, M. M.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S88 - S88
  • [39] The axillary lymph node status (ALNS) of breast cancers by combined ER, PR and HER-2 expression: Triple positive tumours are more likely lymph node positive
    Van Calster, B.
    Neven, R.
    Bempt, I. Vanden
    Pochet, N.
    Cheng, J.
    Vanhuffel, S.
    Hendrickx, W.
    De Cock, J.
    Wildlers, H.
    Paridaens, R.
    Amant, F.
    Berteloot, P.
    Leunen, K.
    Vergote, I.
    Weltens-Leunen, C. -K.
    Van Limbergen, E.
    Smeets-Christiaens, A. -M.
    Christiaens, M. R.
    Drijkoningen, M.
    BREAST, 2007, 16 : S27 - S27
  • [40] Discrepancy of pathologic complete response and outcome between breast tumor and axillary node in HER2-positive breast cancer after neoadjuvant chemotherapy.
    Chu, Chia-Hui
    Chen, Shin-Cheh
    Chang, Hsien-Kun
    Lin, Yung-Chang
    Shen, Shih-Che
    Kuo, Wen-Lin
    Yu, Chi-Chang
    Chou, Hsu-Huan
    Huang, Yi-Ting
    Ueng, Shir-Hwa
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 28 - 29
12345